This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov….
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans…
DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,…
Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER, Sept. 13, 2023 /PRNewswire/ — DaVita Inc….
Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER, Sept. 12, 2023 /PRNewswire/ — DaVita Inc., a leading kidney care provider,…